MENA 2024 Recordings-Post Transplant Diabetes Management

Post Transplant Diabetes Management - Dr. Betul Hatipoglu

Video Transcription

Video Summary

The session centered on post-transplant diabetes mellitus (PTDM), highlighting its importance due to the increased risk of graft loss, cardiovascular events, and mortality in transplant recipients. The speaker emphasized the need to understand and manage PTDM, distinguishing it from pre-existing diabetes, and identified common risk factors including age, gender, obesity, sedentary lifestyle, and genetic predisposition. Transplant-induced factors, such as immunosuppressive medications and infections, also contribute to PTDM. Diagnosis within 45 days post-transplant might be unreliable, hence screening at various intervals is recommended. Treatment involves lifestyle changes and medications, with insulin often used initially. Among oral medications, metformin, DPP-4 inhibitors, and GLP-1 agonists are options, although caution is advised due to potential side effects. SGLT-2 inhibitors are noted for their benefits but need careful monitoring. Overall, early intervention and tailored management strategies employing diverse treatment options are crucial for improving outcomes in PTDM patients.

Keywords

post-transplant diabetes mellitus

graft loss

immunosuppressive medications

lifestyle changes

insulin treatment

metformin